Latest Breaking News On - Technology chengdu - Page 1 : comparemela.com

Industrial application of icariin and baohuoside I has been hindered by the short supply to a great extent. In this work, a novel GH78 α-l-rhamnosidase AmRha catalyzed the bioconversion of low-value epimedin C in crude Epimedium Folium flavonoids (EFs) to icariin and baohuoside I was developed. Firstly, the high-level expression of AmRha in Komagataella phaffii GS115 attained an enzyme activity of 571.04 U/mL. The purified recombinant AmRha could hydrolyze α-1,2-rhamnoside bond between two rhamnoses (α-Rha(2 → 1)α-Rha) in epimedin C to produce icariin with a molar conversion rate of 92.3%, in vitro. Furtherly, the biotransformation of epimedin C to icariin by the recombinant Komagataella phaffii GS115 cells was also investigated, which elevated the EFs concentration by fivefold. In addition, biotransformation of epimedins A-C and icariin in the raw EFs to baohuoside I was fulfilled by a collaboration of AmRha and β-glucosidase/β-xylosidas

United statesDligase takaraTakara bioAmrha genbankBio rad aminexAldrich trading co ltdTechnology chengduJiangsu kanion pharmaceutical coVazyme biotech coGeneray biotech co ltdShanghai aladdin biochemical technology co ltdMicrobiology laboratory nanjing forestry universityShaanxi tianneng co ltdChengdu must bio technologyEpimedium foliumJiangsu kanion pharmaceutical